Patent Valuation Services: A US Patent Owner’s Choice

Compare patent valuation services against the same defined rights package: income/DCF suits credibly forecastable patent-specific income, while a market approach suits sufficiently comparable transactions.[4][8] Commission an asset-value range, not just a royalty recommendation; valuation and negotiated payment terms answer different questions.[4]

Define one licensing assignment before requesting proposals

Give each prospective provider the same engagement brief:

• Purpose: Support [proposed licensing decision], rather than another valuation purpose.[4][8]
• Valuation frame: Value as of [date], using [agreed value basis and assumptions]. Ask the provider to explain the selected basis.[4][8]
• Patents: Include [patent numbers and relevant claims], [family members] and [specified foreign counterparts].[5]
• Rights package: Cover [territory], [exclusive or nonexclusive rights], [field of use] and [remaining patent life].[4][7]
• Proposed deal: Analyze [intended license structure and payment arrangements], keeping asset value distinct from payment terms.[4]

Ask the provider to list included and excluded rights explicitly. Claim scope, family coverage, geography and remaining life affect valuation inputs or transaction comparability.[5][7]

State that company valuation, acquisition accounting, launch clearance and infringement-damages calculation are outside this assignment. Do not import charitable-donation rules into the value basis: IRS Publication 561 addresses donated property, not an ordinary commercial-license negotiation.[2]

Assign legal inputs and isolate patent-specific income

Ask for an assumption register recording each issue, evidence supplied, responsible reviewer and treatment if unresolved. Use it to distinguish supplied legal opinions from untested assumptions about ownership, validity, enforceability and infringement.

Assign responsibility for legal review and ask whether the fee includes additional counsel work. Request the source and date of claim analysis, prosecution and litigation history, and infringement assessments; NovoTech IP identifies these as legal inputs to valuation.[5]

Require an explanation linking product earnings to patent-specific benefits. Ask what projected income is attributed to the patented technology, what is excluded and why. CASRAI’s income approach focuses on patent-attributable income, not the entire product or company.[4]

Put these commercial assumptions on an approval list:

• Revenue forecasts, market penetration, pricing, costs and taxes.[6][7]
• Cash-flow timing, projection period and the risk-adjusted discount rate.[6][7]
• Remaining patent term and useful economic life—the forecast is typically bounded by the remaining term, but economic life may be shorter.[4]

For unresolved inputs, request labeled scenarios rather than allowing assumptions to read as established facts.

Compare valuation approaches against the available evidence

Income/DCF

• Suited to: Existing or credibly forecastable income attributable to the patented technology.[4][8]
• Deliverable: A patent-attributable cash-flow model, discounted to present value.[4]
• Limitation: Results depend heavily on forecasts and the discount rate used to reflect risk.[4][8]

Relief-from-royalty

• Suited to: Assignments with a defensible hypothetical royalty benchmark and a credible revenue forecast.[4]
• Deliverable: The present value of hypothetical royalty payments avoided by owning the patent rather than licensing it.[4]
• Limitation: The assumed royalty rate needs its own justification; the calculation does not independently establish it.[4]

Market approach

• Suited to: Assignments with actual transfers or licenses involving sufficiently similar IP.[4][8]
• Deliverable: An adjusted comparable-deal range considering royalties, upfront payments, milestones and other relevant payment terms.[4][6]
• Limitation: Confidentiality can restrict access to transactions, while differences in rights, development stage and deal circumstances can weaken comparability.[4][6]

Cost approach

• Suited to: Early-stage technology with neither reliable income forecasts nor close transaction comparables.[4][8]
• Deliverable: Documented costs to reproduce the technology or replace it with technology of equivalent utility.[4][8]
• Limitation: Creation cost may have little relationship to licensing value because it does not directly capture demand or profitability.[4][8]

Ask the provider to explain its primary method, any corroborating method and which missing evidence limits the analysis. Relief-from-royalty is an income-method variant, not independent proof of the royalty to demand in negotiations.[4]

Specify the report and its negotiation limits

Put report acceptance criteria in the engagement:

• Assignment: Valuation date, defined rights package, selected methods and reasons those methods fit the available evidence.[4][7]
• Legal inputs: Separate supplied legal conclusions, untested assumptions and unresolved risks.
• Financial evidence: Patent-specific forecasts and projection period, comparable-selection criteria and adjustments, and support for discount rates and hypothetical royalty assumptions.[4][6][7]
• Results: An asset-value range, sensitivity cases and an explanation of differences between methods.[4][6]

Require sensitivity disclosures connecting changes in penetration, pricing or competition to changes in calculated value.[6] If methods produce divergent results, ask the valuer to reassess assumptions and explain the remaining differences—not simply average the numbers.[4]

Keep asset value separate from deal terms. Give any proposed royalty, upfront fee, milestone payments or equity consideration separate treatment: valuation can inform that structure without determining it.[4] Calculated value is not a guaranteed negotiated price.[8]

Choose the provider by its written commitments

Phoenix Strategy Group reports financial-modeling and licensing-negotiation guidance capabilities; these are vendor claims, not independent performance evidence.[6] NovoTech IP and Outlier Patent Attorneys publish educational valuation guidance.[5][7]

As an industry overview, Outlier Patent Attorneys’ valuation guide groups providers into types: IP-focused advisory firms such as Ocean Tomo (now part of J.S. Held), independent valuation firms such as Kroll, the Big 4 accounting firms’ IP practices, and boutique specialists. The same guide puts typical professional valuations at about $10,000–$25,000 for boutique engagements and $100,000+ for complex Big 4 valuations, taking 2–6 weeks.[7] Treat these as general industry ranges, not quotes: confirm price, timing, cancellation terms and whether legal opinions are included with each provider.

What to confirm with each provider

• Assignment and personnel: Will they accept a US standalone licensing valuation? Who will perform and sign it, and what relevant experience do they have?
• Deliverable: Can they provide a redacted sample report showing assumptions, sensitivities and conclusions?
• Price and scope: What does the quoted fee include and exclude, and what triggers additional charges?
• Inputs: Which documents must you supply, who supplies legal-review inputs, and which legal opinions are included?
• Schedule and exit terms: What delivery milestones, revision rounds, cancellation and refund terms apply?
• Use and responsibility: What confidentiality, permitted negotiation use, third-party reliance, update and liability terms will the contract include?

Send the same rights-package brief and report checklist to every shortlisted provider. Favor the proposal that documents assumptions and supports its method choices—not simply the highest suggested value.

References

2. Publication 561 (12/2025), Determining the Value of Donated Property | Internal Revenue Service (irs.gov)
4. Patent Valuation: Income, Market, Cost — CASRAI (casrai.org)
5. Understanding Your Intellectual Property's Worth (novotechip.com, 2024)
6. 5 Methods for Licensing Valuation | PSG (phoenixstrategy.group, 2025)
7. Patent Valuations: More Than Everything You Ever Wanted to Know | Insights | Outlier Patent Attorneys (outlierpatentattorneys.com)
8. Valuing Intellectual Property Assets (wipo.int)